Perlara was originally founded as Perlstein Lab, PBC in February 2014. Perlara is the first biotech Public Benefit Corporation (bioPBC) based in the Bay Area that is on a mission to accelerate the discovery of cures for rare genetic diseases and uncover underlying mechanisms that enable the development of treatments that work across a range of diseases and individuals.
Perlara scientists and our PERLpartners™ are mapping and navigating the Genetisphere. With our PerlArk™ Platform, we launch PerlQuests to find treatments for specific diseases and a growing treasure trove of gene modifiers to apply to gene expressions and interactions across diseases.
We are a diverse team with expertise in genetics, pharmacology, cell biology, data science and automation. We share an enthusiasm for scientific discovery and a commitment to transparency and engagement.